Krish Krishnan S.'s most recent trade in Krystal Biotech Inc was a trade of 13,400 Common Stock done at an average price of $150.3 . Disclosure was reported to the exchange on July 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.30 per share. | 14 Jul 2025 | 13,400 | 1,512,529 (8%) | 0% | 150.3 | 2,014,015 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.30 per share. | 14 Jul 2025 | 13,400 | 1,512,529 (8%) | 0% | 150.3 | 2,014,015 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.29 per share. | 14 Jul 2025 | 13,335 | 1,443,376 (8%) | 0% | 150.3 | 2,004,125 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.29 per share. | 14 Jul 2025 | 13,335 | 1,443,376 (8%) | 0% | 150.3 | 2,004,125 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,236 | 1,441,040 (8%) | 0% | 150.7 | 336,929 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,236 | 1,441,040 (8%) | 0% | 150.7 | 336,929 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,184 | 1,510,345 (8%) | 0% | 150.7 | 329,089 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.68 per share. | 14 Jul 2025 | 2,184 | 1,510,345 (8%) | 0% | 150.7 | 329,089 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,529 | 1,438,711 (8%) | 0% | 150 | 229,350 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,529 | 1,438,711 (8%) | 0% | 150 | 229,350 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,389 | 1,508,056 (8%) | 0% | 150 | 208,350 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 14 Jul 2025 | 1,389 | 1,508,056 (8%) | 0% | 150 | 208,350 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 900 | 1,509,445 (8%) | 0% | 151.8 | 136,611 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 900 | 1,509,445 (8%) | 0% | 151.8 | 136,611 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 800 | 1,440,240 (8%) | 0% | 151.8 | 121,432 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.79 per share. | 14 Jul 2025 | 800 | 1,440,240 (8%) | 0% | 151.8 | 121,432 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.00 per share. | 14 Jul 2025 | 100 | 1,443,276 (8%) | 0% | 151 | 15,100 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.00 per share. | 14 Jul 2025 | 100 | 1,443,276 (8%) | 0% | 151 | 15,100 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.22 per share. | 09 Jul 2025 | 6,627 | 1,526,229 (8%) | 0% | 150.2 | 995,497 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.22 per share. | 09 Jul 2025 | 6,627 | 1,526,229 (8%) | 0% | 150.2 | 995,497 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.23 per share. | 09 Jul 2025 | 6,500 | 1,457,011 (8%) | 0% | 150.2 | 976,464 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.23 per share. | 09 Jul 2025 | 6,500 | 1,457,011 (8%) | 0% | 150.2 | 976,464 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,456,711 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,525,929 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,525,929 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,456,711 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.14 per share. | 09 Jul 2025 | 200 | 1,463,511 (8%) | 0% | 150.1 | 30,028 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.07 per share. | 09 Jul 2025 | 200 | 1,532,856 (8%) | 0% | 150.1 | 30,014 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.07 per share. | 09 Jul 2025 | 200 | 1,532,856 (8%) | 0% | 150.1 | 30,014 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.14 per share. | 09 Jul 2025 | 200 | 1,463,511 (8%) | 0% | 150.1 | 30,028 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 177.66 per share. | 13 Mar 2025 | 10,937 | 1,471,556 (8%) | 0% | 177.7 | 1,943,027 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 177.66 per share. | 13 Mar 2025 | 10,937 | 1,471,556 (8%) | 0% | 177.7 | 1,943,027 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 177.62 per share. | 13 Mar 2025 | 10,931 | 1,541,081 (8%) | 0% | 177.6 | 1,941,611 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 177.62 per share. | 13 Mar 2025 | 10,931 | 1,541,081 (8%) | 0% | 177.6 | 1,941,611 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 178.77 per share. | 13 Mar 2025 | 6,769 | 1,534,312 (8%) | 0% | 178.8 | 1,210,077 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 178.77 per share. | 13 Mar 2025 | 6,769 | 1,534,312 (8%) | 0% | 178.8 | 1,210,077 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 178.76 per share. | 13 Mar 2025 | 6,514 | 1,465,042 (8%) | 0% | 178.8 | 1,164,415 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 178.76 per share. | 13 Mar 2025 | 6,514 | 1,465,042 (8%) | 0% | 178.8 | 1,164,415 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 176.80 per share. | 13 Mar 2025 | 4,944 | 1,552,012 (8%) | 0% | 176.8 | 874,123 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 176.80 per share. | 13 Mar 2025 | 4,944 | 1,552,012 (8%) | 0% | 176.8 | 874,123 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 176.88 per share. | 13 Mar 2025 | 4,579 | 1,482,493 (8%) | 0% | 176.9 | 809,924 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 176.88 per share. | 13 Mar 2025 | 4,579 | 1,482,493 (8%) | 0% | 176.9 | 809,924 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 175.97 per share. | 13 Mar 2025 | 1,639 | 1,487,072 (8%) | 0% | 176.0 | 288,419 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 175.97 per share. | 13 Mar 2025 | 1,639 | 1,487,072 (8%) | 0% | 176.0 | 288,419 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 179.55 per share. | 13 Mar 2025 | 1,331 | 1,463,711 (8%) | 0% | 179.5 | 238,977 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 179.55 per share. | 13 Mar 2025 | 1,331 | 1,463,711 (8%) | 0% | 179.5 | 238,977 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 179.57 per share. | 13 Mar 2025 | 1,256 | 1,533,056 (8%) | 0% | 179.6 | 225,544 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 179.57 per share. | 13 Mar 2025 | 1,256 | 1,533,056 (8%) | 0% | 179.6 | 225,544 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 175.83 per share. | 13 Mar 2025 | 1,100 | 1,556,956 (8%) | 0% | 175.8 | 193,408 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 175.83 per share. | 13 Mar 2025 | 1,100 | 1,556,956 (8%) | 0% | 175.8 | 193,408 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 39,300 | 39,300 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 26,250 | 1,570,205 (9%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 26,250 | 26,250 | - | - | Performance Stock Units | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 26,250 | 1,574,926 (9%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 22,900 | 22,900 | - | - | Restricted Stock Units | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 22,500 | 1,502,411 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 22,500 | 1,499,125 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 22,500 | 22,500 | - | - | Performance Stock Units | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 16,000 | 16,000 | - | - | Restricted Stock Units | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 12,500 | 1,545,041 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 12,500 | 0 | - | - | Performance Stock Units | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 12,500 | 1,549,762 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 12,149 | 1,558,056 (9%) | 0% | 179.2 | 2,177,708 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 12,149 | 1,562,777 (9%) | 0% | 179.2 | 2,177,708 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 10,414 | 1,491,997 (8%) | 0% | 179.3 | 1,866,710 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 10,414 | 1,488,711 (8%) | 0% | 179.3 | 1,866,710 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 8,750 | 1,548,005 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 8,750 | 26,250 | - | - | Restricted Stock Units | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 8,750 | 1,552,726 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 7,500 | 1,483,382 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 7,500 | 1,480,096 (8%) | 0% | 0 | Common Stock | |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 7,500 | 0 | - | - | Performance Stock Units | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 5,786 | 1,539,255 (8%) | 0% | 179.3 | 1,037,141 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 5,786 | 1,543,976 (8%) | 0% | 179.3 | 1,037,141 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.39 per share. | 26 Feb 2025 | 4,721 | 1,532,541 (8%) | 0% | 176.4 | 832,737 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.39 per share. | 26 Feb 2025 | 4,721 | 1,558,056 (9%) | 0% | 176.4 | 832,737 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 4,050 | 1,543,955 (8%) | 0% | 179.3 | 725,963 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 4,050 | 1,548,676 (8%) | 0% | 179.3 | 725,963 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 3,471 | 1,479,911 (8%) | 0% | 179.3 | 622,177 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 179.25 per share. | 26 Feb 2025 | 3,471 | 1,476,625 (8%) | 0% | 179.3 | 622,177 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.39 per share. | 26 Feb 2025 | 3,286 | 1,488,711 (8%) | 0% | 176.4 | 579,618 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 176.39 per share. | 26 Feb 2025 | 3,286 | 1,472,596 (8%) | 0% | 176.4 | 579,618 | Common Stock |
| Krystal Biotech Inc | M. Krishnan Suma | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.92 per share. | 13 Dec 2024 | 8,923 | 1,486,017 (8%) | 0% | 163.9 | 1,462,617 | Common Stock |
| Krystal Biotech Inc | Krishnan Krish S. | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.92 per share. | 13 Dec 2024 | 8,923 | 1,486,017 (8%) | 0% | 163.9 | 1,462,617 | Common Stock |
| Krystal Biotech Inc | M. Suma Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.91 per share. | 13 Dec 2024 | 8,381 | 1,547,579 (8%) | 0% | 163.9 | 1,373,756 | Common Stock |
| Krystal Biotech Inc | S. Krish Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.91 per share. | 13 Dec 2024 | 8,381 | 1,547,579 (8%) | 0% | 163.9 | 1,373,756 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.07 per share. | 13 Dec 2024 | 6,302 | 1,555,960 (8%) | 0% | 163.1 | 1,027,661 | Common Stock |
| Krystal Biotech Inc | S. Krish Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.07 per share. | 13 Dec 2024 | 6,302 | 1,555,960 (8%) | 0% | 163.1 | 1,027,661 | Common Stock |
| Krystal Biotech Inc | Krishnan M. Suma | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.04 per share. | 13 Dec 2024 | 5,942 | 1,494,940 (8%) | 0% | 163.0 | 968,804 | Common Stock |
| Krystal Biotech Inc | S. Krishnan Krish | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 163.04 per share. | 13 Dec 2024 | 5,942 | 1,494,940 (8%) | 0% | 163.0 | 968,804 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.93 per share. | 13 Dec 2024 | 4,909 | 1,542,670 (8%) | 0% | 164.9 | 809,644 | Common Stock |
| Krystal Biotech Inc | Krishnan Krish S. | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.93 per share. | 13 Dec 2024 | 4,909 | 1,542,670 (8%) | 0% | 164.9 | 809,644 | Common Stock |
| Krystal Biotech Inc | S. Krish Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.92 per share. | 13 Dec 2024 | 4,723 | 1,481,294 (8%) | 0% | 164.9 | 778,894 | Common Stock |
| Krystal Biotech Inc | Krishnan Suma M. | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 164.92 per share. | 13 Dec 2024 | 4,723 | 1,481,294 (8%) | 0% | 164.9 | 778,894 | Common Stock |
| Krystal Biotech Inc | M. Krishnan Suma | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.79 per share. | 13 Dec 2024 | 2,114 | 1,479,180 (8%) | 0% | 165.8 | 350,490 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.79 per share. | 13 Dec 2024 | 2,114 | 1,479,180 (8%) | 0% | 165.8 | 350,490 | Common Stock |
| Krystal Biotech Inc | Krishnan Suma M. | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.82 per share. | 13 Dec 2024 | 1,977 | 1,540,693 (8%) | 0% | 165.8 | 327,833 | Common Stock |
| Krystal Biotech Inc | S. Krish Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 165.82 per share. | 13 Dec 2024 | 1,977 | 1,540,693 (8%) | 0% | 165.8 | 327,833 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.47 per share. | 13 Dec 2024 | 957 | 1,537,902 (8%) | 0% | 170.5 | 163,139 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.47 per share. | 13 Dec 2024 | 957 | 1,537,902 (8%) | 0% | 170.5 | 163,139 | Common Stock |